tert-Butyl (E)-3-(pyridin-2-yl)acrylate, 97%, 500mg

5-Methyl-2-(trifluoromethyl)furan, 98.0%, 250mg

2,3,4-Trifluorobenzoic acid, 98.0%, 500g

2-(3,5-Dichlorophenyl)cyclopropane-1-carboxylic acid, 98%, 250mg

3-(1-ACETYL-PIPERIDIN-4-YL)-PROPIONIC ACID, 97.0%, 1g

2,4-Diphenylpyridine, 95.0%, 1g

6-Hydrazinyl-1H-indazole tetrahydrochloride, 95%, 250mg

3-Fluoro-5-nitrobenzaldehyde, 95.0%, 1g

ethyl 4-(naphthalen-1-yl)-3-oxobutanoate, 95.0%, 2g

bScope BS.1153-PLPHi for phase contrast. Triocular with HWF 10x/20 mm eyepieces and quintuple revolver E-plan Phase IOS 10/20/S40 S100x

4-Bromo-9H-carbazole, 95.0%, 25g

ETHYL 6-CHLORO-1H-INDAZOLE-3-CARBOXYLATE, 95%, 250mg

3-Decylthiophene, 95.0%, 10g